MedPath

The effect of herbal tea on improving respiratory symptoms in patients with Covid-19

Phase 3
Conditions
COVID-19 disease.
COVID-19 disease
U07.1
Registration Number
IRCT20200806048318N1
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
80
Inclusion Criteria

Positive result of PCR or CT SCAN of COVID-19 disease in accordance with international standards
Age 60-15 years
Patient consent to participate in the study

Exclusion Criteria

Has diseases such as Alzheimer's, Parkinson's, multiple sclerosis, neuromuscular diseases, myasthenia gravis
Pregnant women
Patients with blood pressure lower than 40/90 mmHg
Breathe more or equal to 30 per minute
Blood oxygen saturation less than 93% at rest
PaO2 to FiO2 ratio less than or equal to 300 mmHg
Patients with more than 50% of exudative lesions in 24-48 hours in the lung image

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Respiratory rate. Timepoint: Before the intervention and the first to fifth days of treatment. Method of measurement: Observation.;Number of coughs. Timepoint: Before the intervention and the first to fifth days of treatment. Method of measurement: Observation.;Percentage of oxygen saturation. Timepoint: Before the intervention and the first to fifth days of treatment. Method of measurement: Pulse Oximeter device.;Shortness of breath. Timepoint: Before the intervention and the first to fifth days of treatment. Method of measurement: Observation.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath